pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Orthopedics · news · pharmadog
← back to Orthopedics
News · Orthopedics
74
stories
14h
Regeneron to challenge Ipsen as FDA clears bone disease drug
biopharma dive
17h
STAT+: FDA approves Ultragenyx gene therapy
stat
18h
STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
stat
18h
Regeneron wins FDA approval to challenge Ipsen for rare bone disease market
biospace
22h
Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
stat
1d
FDA approves Regeneron’s garetosmab for disease that turns tissue to bone
endpoints
1d
Amgen abandoning $500M+ Crohn’s collab won’t derail TScan’s pipeline strategy
fiercebiotech
1d
STAT+: Experts scrutinize Huidagene’s disclosures after patient death
stat
1d
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
stat
2d
BioMarin acquires experimental drug for rare bone disorder in $275M deal
biopharma dive
2d
BioMarin does another small deal to get early-stage bone disease asset
endpoints
2d
BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZeneca
fiercebiotech
6d
Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene
biopharma dive
10d
STAT+: The promise of radiopharmaceuticals smacks into safety concerns
stat
10d
FDA issues alert in wake of BD recall of faulty needle sets
fiercebiotech
11d
Silence brings the noise to Takeda with phase 2 blood cancer win
fiercebiotech
13d
BlossomHill, Latigo outshine IPO expectations with oversubscribed debuts
fiercebiotech
14d
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
fda press
15d
Opinion: Tear down the wall between M.D. and D.O. education
stat
16d
Hinge Health will buy Cylinder Health for $105M to enter digestive care
endpoints
16d
Sanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journey
fiercebiotech
16d
Smith & Nephew cuts 2026 outlook as US knee implant sales slide
fiercebiotech
16d
Latigo laces up for $247M IPO to fund non-opioid pain drug rival to Vertex’s Journavx
fiercebiotech
17d
STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case
stat
21d
Ebola outbreak nears milestone, while a vaccine remains months away
stat
21d
Opinion: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases
stat
22d
New funding, new jobs: 4 biotechs hiring after series B raises
biospace
22d
GSK pens $110M biological datasets pact with AI biotech Relation
fiercebiotech
22d
Convenience Kit Correction: Argon Medical Issues Correction for Convenience Kits Containing Spectra Medical Device Lidocaine Ampules
fda medwatch
23d
Biotechs bring big launches and pharma rivalries into Q2 earnings period
biospace
← prev
page 1 of 3
next →
